title: vastus lateralis, protein intake:0.50 g/kg, young, subject 9

description: Gene expression for young male following two weeks of dietary protein intake of 0.50 g/kg


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 13

status: Public on Sep 22 2008

type: RNA

city: West Lafayette

first: Wayne

last: Campbell

state: IN

address: 700 West State Street

department: Foods and Nutrition

country: USA

institute: Purdue University

hyb_protocol: Affymetrix protocol

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner

data_processing: The raw data were summarized using Affymetrix Microarray Suite (MAS) 5.0 software

label: biotin

molecule: total RNA

organism: Homo sapiens

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from a minimum of 5 ug total RNA

extract_protocol: Total RNA was isolated from the frozen muscle sample using Tri-Reagent following the manufacturerÆs instructions.  Isolated total RNA was further purified using RNeasy Mini Kits following manufacturerÆs protocol

treatment_protocol: Three randomized controlled feeding trials with protein intakes of 63% (P63: 0.50 g/kg-1/d-1), 94% (P94: 0.75 g/kg-1/d-1), and 125% (P125: 1.00 g/kg-1/d-1) of the recommended dietary allowance (RDA).

tag: Protein intake:0.50 g/kg

tag: Sex

value: Male

tag: Age


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 9

description: Gene expression for younger male following 2 weeks of dietary protein intake of 0.75 g/kg

tag: Protein intake

tag: Trial


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 14


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 5


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 7


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 11


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 8


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 5


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 12


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 7


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 8


title: vastus lateralis, protein intake: 1.00 g/kg, old, subject 3

description: Gene expression for older male following two weeks of dietary protein intake 1.00 g/kg


title: Murine normal cells_rep 1

city: Oxford

first: Dilair

last: Baban

address: Roosevelt Drive

department: Wellcome Trust Centre Human Genetics

country: United Kingdom

institute: University of Oxford

description: Here we have investigated the invasion of lymphatic vessels as a key step in the metastasis of primary tumour cells to draining lymph nodes by comparing the gene expression profile of normal dermal lymphatic endothelial cells (LEC) with those isolated from tumours of murine T-241/VEGF-C metastatic fibrosarcoma.

hyb_protocol: Fragmented labeled cRNA (15 µg) was used in 300 µl hybridization cocktail containing spiked controls (Affymetrix #900299). A 200 µl sample of this hybridization cocktail was used on the chip and incubated at 45°C for 16 h in the hybridization oven, rotating at 60 rpm. Following hybridization, the arrays were processed using a Genechip Fluidics Station 400 according to recommended protocols (EukGE-WS2v5, Affymetrix) of double-staining and post-hybridizations washes.

scan_protocol: Fluorescent images were captured using gene Array Scanner 3000 and GCOS1.2 software (Affymetrix).

data_processing: We have used the GeneChip Robust Multi-array Average expression measurements (GC-RMA) as implemented in BioConductor R statistics (www.bioconductor.org). Cell Intensity files (CEL) were used to obtain expression values for all the 45,101 probe sets (transcripts) on each of these arrays.

label: Biotin

organism: Mus musculus

source_name: Normal dermal LEC were isolated from C57BL/6 mice.

label_protocol: 50ng total RNA used in Affymetrix two cycle labelling kit cat. no. 900494

growth_protocol: Mouse LEC were grown in gelatin-coated tissue culture flasks in EGM-2 medium at 37ºC, 5 % CO2 in a humidified atmosphere.

extract_protocol: Total RNA extracted using Qiagen RNeasy.

treatment_protocol: Normal dermal LEC were isolated from the tail skin of 8-week old female C57Bl6 mice. Skin was incubated at 4°C overnight in PBS containing 2mg/ml dispase before removing the epidermis. The dermis was then scraped to release endothelial cells, which were collected by centrifugation before culture. LEC were purified, after lifting with accutase®, by immunomagnetic selection with rabbit anti-mouse LYVE-1 and goat anti-rabbit MACS® beads according to the manufacturers instructions

tag: Normal dermal LEC were isolated from the tail skin of 8-week old female C57BL/6 mice.


title: vastus lateralis, protein intake: 1.00 g/kg, old, subject 4


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 10


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 6


title: vastus lateralis, protein intake: 0.75 g/kg, old, subject 3

description: Gene expression for older male following 2 weeks of dietary protein intake of 0.75 g/kg


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 2


title: vastus lateralis, protein intake:0.50 g/kg, old, subject 3

description: Gene expression for older male following two weeks of dietary protein intake of 0.50 g/kg


title: vastus lateralis, protein intake: 1.00 g/kg, young, subject 2

description: Gene expression for younger male following two weeks of dietary protein intake 1.00 g/kg


title: vastus lateralis, protein intake: 1.00 g/kg, young, subject 1


title: vastus lateralis, protein intake: 0.75 g/kg, old, subject 4


title: vastus lateralis, protein intake: 0.75 g/kg, young, subject 1


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 2


title: vastus lateralis, protein intake:0.50 g/kg, old, subject 4


title: vastus lateralis, protein intake:0.50 g/kg, young, subject 1


title: LEC_siRNA_NR2F2

status: Public on Sep 20 2008

city: Los Angeles

first: Young-Kwon

last: Hong

state: CA

address: 1450 Biggy St. NRT6501

institute: University of Southern California

description: Followed Affymetrix One Cycle Expression kit manual

source_name: Primary human lymphatic endothelial cells with NR2F2 knockdown

extract_protocol: Tri-reagent

tag: Primary lymphatic endothelial cells from human foreskin, siRNA for NR2F2


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Bgh inoculated - rep2

type: other

city: Ames

first: PLEXdb Curator

middle: Sudhansu

state: IA

address: 1023  Crop Genomes Informatics Lab (Iowa State University)

department: Virtual Reality Application Center

institute: Iowa State University

description: Eight complete rosettes (Boyes' growth stage 3.90) of ataf1-1 mutant allelic plants 12 hrs after inoculation with Bgh.

hyb_protocol: Affymetrix GeneChip method

scan_protocol: Affy- Array Scanning

data_processing: The MAS5.0 Normalization is performed using the justMAS function in the simpleaffy package of Bioconductor (www.bioconductor.org). The target value is 500 for all cases. The code was developed using R2.4.1, Bioconductor 1.9, and simpleaffy 2.8.0. The CDF files were downloaded from the Bioconductor website at http://www.bioconductor.org/packages/release/AffymetrixChip.html. The normalization scripts are available from the PLEXdb team by request.

molecule: other

organism: Arabidopsis thaliana

source_name: rosette leaf (genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Bgh inoculated)

label_protocol: Affy-Eukaryotic Target Preparation for mRNA

growth_protocol: Growth Description:  Plants were grown in a growth chamber (PERCIVAL)(20-22 oC) under a short day (SD) photoperiod (8hrs/16hrs) from lamps (125 uE m-2 s-1).  Environmental Conditions:  Growth chamber

extract_protocol: Arabidopsis protocol based on Qiagen RNeasy treatment

tag: Arabidopsis thaliana ecotype Columbia-0, homozygote Salk line N567648 (Germplasm Name); Columbia-0 (Ecotype); PO:0000014 rosette leaf, (Organism Part); PO:0007078 rosette growth complete (Development Stage); 6-weeks after germination (Age); compost (Growth Media).


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Bgh inoculated - rep1

description: Eight complete rosettes (Boyes' growth stage 3.90) of wild-type Col-0 plants 12 hrs after Bgh inoculation.

source_name: rosette leaf (genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Bgh inoculated)

tag: Arabidopsis thaliana ecotype Columbia-0 (Germplasm Name); Columbia-0 (Ecotype); PO:0000014 rosette leaf, (Organism Part); PO:0007078 rosette growth complete (Development Stage); 6-weeks after germination (Age); compost (Growth Media).


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Un-inoculated - rep2

description: Eight complete un-inoculated rosettes (Boyes' growth stage 3.90) of ataf1-1 mutant allelic plants.

source_name: rosette leaf (genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Un-inoculated)


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Un-inoculated - rep3


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Bgh inoculated - rep2


title: OVCAR8 RIA transfectant 1

city: baltimore

first: chris

last: cheadle

state: MD

address: 5200 Eastern Ave

department: SOM

institute: JHU

description: DCT-Tumor Repository (NCI)

hyb_protocol: Following fragmentation, 20 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array.  GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Affymetrix GeneArray Scanner G2500A.

data_processing: The data were analyzed with the Affymetrix Expression Console Software using the Robust Multichip Analysis (RMA) default analysis settings as the normalization method.

source_name: OVCAR8 RIA transfectant

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: OVCAR-8 cells were grown in RPMI Medium 1640 supplemented with 10% heat-inactivated fetal bovine serum, MEM non-essential amino acids, and antibiotic-antimycotic, in a humidified incubator (95% air and 5% CO2) at 37⁰C.

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.  Additional purification was performed on RNAeasy columns.

treatment_protocol: The stable transfectants, containing retroviral vectors OT1521 or OT1529 with the internal inducible mouse metallothionine-1 (MT-1) promoter, and genes encoding PKA subunits RIα and RIIβ were treated with 60 uM ZnSO4 for 6 days prior to the start of the experiment.  To exclude other effects of Zn++, parental cells were treated with ZnSO4 in the same manner as transfected cells.


title: LEC_siRNA_control

description: Followed Affymetrix One Cycle Gene Expression kit manual

hyb_protocol: Followed Affymetrix One Cycle Expression kit manual

source_name: Primary human lymphatic endothelial cells with control knockdown

tag: Primary lymphatic endothelial cells from human foreskin, siRNA for luciferase


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Bgh inoculated - rep1


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Un-inoculated - rep1


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Un-inoculated - rep1

description: Eight complete un-inoculated rosettes (Boyes' growth stage 3.90) of wild-type Col-0 plants.

source_name: rosette leaf (genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Un-inoculated)


title: genotype: ataf1-1 mutant, ecotype Col-0 - treated or untreated: Bgh inoculated - rep3


title: OVCAR8 RIIB transfectant 1

description: DCT-Tumor Repository (NCI)

source_name: OVCAR8 RIIB transfectant


title: OVCAR8 parental cells 2

description: DCT-Tumor Repository (NCI)

source_name: OVCAR8 parental cells


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Bgh inoculated - rep3


title: OVCAR8 parental cells 1

description: DCT-Tumor Repository (NCI)


title: LEC_siRNA_Prox1

scan_protocol: Followed Affymetrix One Cycle Expression kit manual

source_name: Primary human lymphatic endothelial cells with Prox1 knockdown

tag: Primary lymphatic endothelial cells from human foreskin, siRNA for Prox1


title: OVCAR8 RIA transfectant 3

description: DCT-Tumor Repository (NCI)


title: OVCAR8 RIA transfectant 2

description: DCT-Tumor Repository (NCI)


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Un-inoculated - rep3

description: Eight complete un-inoculated rosettes (Boyes' growth stage 3.90)of wild-type Col-0 plants.


title: genotype: Wild-type Arabidopsis, ecotype Col-0 - treated or untreated: Un-inoculated - rep2


title: B2KO; Isoproterenol-treated #10

status: Public on Sep 19 2008

city: stanford

first: Rani

last: Agrawal

address: 300 Pasteur Drive, Dept of Anesthesia

department: Anesthesia

institute: Stanford University

description: Gene expression data from mice heart

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip 430-2 Mouse Gene array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.

scan_protocol: GeneChips were scanned using the Genechip Scanner 3000.

data_processing: GC-RMA

source_name: Heart

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 10 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)

extract_protocol: Twenty WT FVB, WT C57, and B2KO mice were given intraperitoneal injections of avertin (100μl/10g body weight) and sacrificed by cervical dislocation.  Half of the mice in each group had undergone fourteen day isoproterenol infusions.  RNA was extracted from the mouse hearts using Quiagen RNeasy® Midi kit.  Samples were homogenized in buffer containing guanidine isothiocyanate and beta mercaptoethanol.  Ethanol was then added to the lysate.  The sample was then applied to the RNeasy column.  RNA was eluted from the column using 80 ul of RNase-free water.

treatment_protocol: Mice of each genotype were randomly assigned to fourteen day infusions of isoproterenol (120 µg/g/day) or no treatment

tag: 10 weeks old


title: B2KO; Isoproterenol-treated #11

description: Gene expression data from mice heart


title: OVCAR8 RIIB transfectant 3

description: DCT-Tumor Repository (NCI)


title: B2KO; Isoproterenol-treated #5

description: Gene expression data from mice heart


title: B2KO; Isoproterenol-treated #8

description: Gene expression data from mice heart


title: B2KO; No Treatment #10

description: Gene expression data from mice heart


title: B2KO; No Treatment #9

description: Gene expression data from mice heart


title: B2KO; Isoproterenol-treated #1

description: Gene expression data from mice heart


title: B2KO; No Treatment #8

description: Gene expression data from mice heart


title: OVCAR8 RIIB transfectant 2

description: DCT-Tumor Repository (NCI)


title: B2KO; Isoproterenol-treated #7

description: Gene expression data from mice heart


title: B2KO; Isoproterenol-treated #3

description: Gene expression data from mice heart


title: B2KO; No Treatment #7

description: Gene expression data from mice heart


title: B2KO; Isoproterenol-treated #6

description: Gene expression data from mice heart


title: B2KO; Isoproterenol-treated #2

description: Gene expression data from mice heart


title: B2KO; No Treatment #4

description: Gene expression data from mice heart


title: B2KO; No Treatment #1

description: Gene expression data from mice heart


title: LEC_siRNA_Prox1/NR2F2

source_name: Primary human lymphatic endothelial cells with Prox1/NR2F2 double knockdown

label_protocol: Followed Affymetrix One Cycle Expression kit manual

tag: Primary lymphatic endothelial cells from human foreskin, siRNA for Prox1 & NR2F2


title: B2KO; No Treatment #2

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #8

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #7

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #11

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #9

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #12

description: Gene expression data from mice heart


title: B2KO; No Treatment #5

description: Gene expression data from mice heart


title: B2KO; No Treatment #6

description: Gene expression data from mice heart


title: B2KO; No Treatment #3

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #4

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #10

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #5

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #6

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #3

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #2

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #9

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #3

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #10

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #6

description: Gene expression data from mice heart


title: OVCAR8 parental cells 3

description: DCT-Tumor Repository (NCI)


title: C57BL/6; Isoproterenol-treated #7

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #9

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #5

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #1

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #6

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #2

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #7

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #8

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #2

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #8

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #11

description: Gene expression data from mice heart


title: B6129SF2/J; Isoproterenol-treated #1

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #3

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #1

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #5

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #10

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #8

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #7

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #6

description: Gene expression data from mice heart


title: C57BL/6; Isoproterenol-treated #4

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #9

description: Gene expression data from mice heart


title: B6129SF2/J; No Treatment #4

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #3

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #4

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #12

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #3

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #5

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #7

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #1

description: Gene expression data from mice heart


title: C57BL/6; No Treatment #2

description: Gene expression data from mice heart


title: FVB; No Treatment #4

description: Gene expression data from mice heart


title: FVB; No Treatment #1

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #11

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #5

description: Gene expression data from mice heart


title: FVB; No Treatment #3

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #2

description: Gene expression data from mice heart


title: FVB; No Treatment #6

description: Gene expression data from mice heart


title: FVB; No Treatment #10

description: Gene expression data from mice heart


title: FVB; No Treatment #7

description: Gene expression data from mice heart


title: FVB; No Treatment #2

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #4

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #6

description: Gene expression data from mice heart


title: FVB; No Treatment #9

description: Gene expression data from mice heart


title: FVB; No Treatment #8

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #10

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #9

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #1

description: Gene expression data from mice heart


title: FVB; No Treatment #5

description: Gene expression data from mice heart


title: FVB; Isoproterenol-treated #8

description: Gene expression data from mice heart


title: liver-AHRWT-TCDD rep 6

city: Toronto

first: Paul

middle: C

last: Boutros

state: Ontario

address: 101 College Street, Suite 800

country: Canada

institute: Ontario Institute for Cancer Research

description: mouse liver, AHR wildtype, 1000 ug/kg TCDD treated, 19 hours

hyb_protocol: Manufacturer's protocol

scan_protocol: Manufacturer's protocol

data_processing: Array data were loaded into the R statistical package (version 2.0.0) using the affy package (version 1.5.8; http://www.bioconductor.org) (Gautier et al., 2004) of the BioConductor open-source project (Gentleman et al., 2004). Data were investigated for spatial and distributional homogeneity, then preprocessed with a sequence-specific version of the RMA algorithm (Irizarry et al., 2003) termed GCRMA, as implemented in BioConductor (version 1.1.3).

source_name: liver-AHRWT-TCDD

label_protocol: Manufacturer's protocol

growth_protocol: Male Ahr–/– mice (10 weeks old) in a C57BL/6J background were obtained from The Jackson Laboratory (Bar Harbor, ME). Wild-type (Ahr+/+) male C57BL/6J mice (15 weeks old) were bred at the National Public Health Institute (Kuopio, Finland) from stock originally obtained from The Jackson Laboratory.

extract_protocol: Liver was harvested 19 h after treatment, sliced, snap-frozen, and stored in liquid nitrogen until homogenization. Total RNA was extracted using RNeasy kits (QIAGEN, Valencia, CA) according to the manufacturer's instructions. DNase (QIAGEN) was added to the RNeasy elution column as recommended by the manufacturer. RNA yield was quantified by UV spectrophotometry, and RNA integrity was verified using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).

treatment_protocol: Mice were given a single dose of 1000 µg/kg TCDD or corn oil vehicle by gavage. TCDD initially was dissolved in ether and added to corn oil; the ether subsequently was evaporated off. TCDD was purchased from the UFA-Oil Institute (Ufa, Russia) and was >99% pure as determined by gas chromatography-mass spectrometry.


title: liver-AHRWT-cornoil rep 5

description: mouse liver, AHR wildtype, cornoil treated, 19 hours

source_name: liver-AHRWT-cornoil


title: liver-AHRWT-TCDD rep 4


title: liver-AHRWT-TCDD rep 2


title: liver-AHRWT-TCDD rep 3


title: liver-AHRWT-TCDD rep 5


title: liver-AHRWT-TCDD rep 1


title: liver-AHRWT-cornoil rep 4


title: mtestis_D30pp_rep2

status: Public on Sep 18 2008

city: Pullman

first: Lizhong

last: Yang

state: WA

address: 531 Fulmer Hall/POB 644660

department: School of Molecular Biosciences

institute: Washington State University

description: All methodology for this dataset is identical to the previously posted dataset generated on the U74 chips.

hyb_protocol: Standard hybridization protocol using 15ug cRNA wash/stain protocol EukGe-2v5-450

scan_protocol: Affymetrix GeneChip® Operating Software (GCOS) automates the control of GeneChip® Fluidics Stations and Scanners. In addition, GCOS acquires data, manages sample and experimental information, and performs gene expression data analysis.

data_processing: For each microarray, probe set signal values were initially normalized by scaling to a target intensity of 125.

source_name: Murine postpartum testis development Day 30

label_protocol:
GeneChip Expression 3' - Amplification one-cycle cDNA synthesis kit (lpn-900431)
GeneChip Expression 3' - Amplification Reagents for IVT labelling (lpn-900449)

extract_protocol: Trizol

tag: Time course of gene expression in the murine postpartum testis development (from day 0 to day 35)


title: mtestis_D18pp_rep1

source_name: Murine postpartum testis development Day 18


title: B6129SF2/J; No Treatment #10

description: Gene expression data from mice heart


title: liver-AHRWT-cornoil rep 3


title: liver-AHRWT-cornoil rep 2


title: liver-AHRWT-cornoil rep 1


title: mtestis_D14pp_rep2

source_name: Murine postpartum testis development Day 14


title: mtestis_D30pp_rep1


title: mtestis_D35pp_rep2

source_name: Murine postpartum testis development Day 35


title: mtestis_D18pp_rep2

source_name: Murine postpartum testis development Day 0


title: mtestis_D35pp_rep1


title: mtestis_D3pp_rep1

source_name: Murine postpartum testis development Day 3


title: mtestis_D14pp_rep1


title: mtestis_D6pp_rep1

source_name: Murine postpartum testis development Day 6


title: mtestis_D20pp_rep1

source_name: Murine postpartum testis development Day 20


title: mtestis_D10pp_rep1

source_name: Murine postpartum testis development Day 10


title: mtestis_D3pp_rep2


title: mtestis_D8pp_rep1

source_name: Murine postpartum testis development Day 8


title: mtestis_D20pp_rep2


title: mtestis_D6pp_rep2


title: mtestis_D10pp_rep2


title: mtestis_D0pp_rep1


title: Apex_BLS>>TCP4_14DAS_1

status: Public on Sep 17 2008

city: Rehovot

first: Idan

middle: D.

last: Efroni

address: Weizmann

country: Israel

institute: Weizmann Institute

hyb_protocol: Standard affymetrix protocol

scan_protocol: Standard affymetrix protocol

data_processing: Values obtained using MAS5. Median was normalized to 50.

label: Standard affymetrix protocol

source_name: Arabidopsis thaliana vegetative apices, BLS>>TCP4 , 14DAS

label_protocol: Standard affymetrix protocol

growth_protocol: Soil grown at short days (10 hours light), 20C

extract_protocol: Using qiagen RNAEasy kit, according to manufacturer protocol

tag: Ecotype

value: Ler

tag: Plants overexpressing a microRNA resistant version of TCP4 under the leaf specific BLS promoter.


title: Apex_BLS>>TCP4_14DAS_2

tag: Plants overexpressing a microRNA resistant TCP4 under the leaf specific BLS promoter


title: Apex_octa_18DAS_2

source_name: Arabidopsis thaliana vegetative apices, octa, 18DAS

value: Col

tag: Plants overexpressing the endogenous microRNA 319b, and the artificial microRAN miR-3TCP, targeting TCP5, TCP13 and TCP17 under 35S promoter. Effectively, all eight CIN-TCP genes are knocked down


title: mtestis_D8pp_rep2


title: Apex_mir-319b_17DAS_1

source_name: Arabidopsis thaliana vegetative apices, 35S:319b, 17DAS

tag: Plants overexpressing the endogenous microRNA 319b under 35S promoter


title: Apex_mir-3TCP_14DAS_2

source_name: Arabidopsis thaliana vegetative apices, 35S:miR-3TCP, 14DAS

tag: Plants overexpressing an artificial microRNA, miR-3TCP, targeting the CIN-TCPs

value: TCP5, TCP13 and TCP17.


title: Apex_octa_18DAS_1


title: Apex_mir-3TCP_14DAS_1


title: Apex_mir-319b_17DAS_2


title: mtestis_D0pp_rep2


title: Apex_Col_14DAS_1

source_name: Arabidopsis thaliana vegetative apices, 14DAS


title: Sample 4 AEC-conditioned MDDC, day 5

status: Public on Sep 16 2008

city: Subiaco

first: Angela

last: Rate

state: Western Australia

address: 100 Roberts Rd

department: Cell Biology

country: Australia

institute: Telthon Institute for Child Health Research

description: Gene expression data from MDDC isolated after 5 days of IL-4/GM-CSF-induced differentiation in the presence of AEC

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix U133Plus2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the GeneChip Scanner 3000 7G

data_processing: Microarray data were analysed in the open-source statistical software R using the probe-level model (PLM) algorithm for backgound subtraction, normalisation and summarisation of probe set intensities.

source_name: AEC-conditioned MDDC, day 5

label_protocol: Labeled cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: 16HBE 14o- epithelial cells were grown to semiconfluency in EMEM media supplemented with 10% FCS before CD14+ peripheral blood monocytes were added to the AEC with recombinant IL-4 and GM-CSF.  In parallel, monocytes were added to empty wells in media with IL-4/GM-CSF without the presence of the AEC.  Cells were cultured for 5 days at 37°C and 5%CO2 with media supplementation on day 3.

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: Following 5 days of culture, total cells from the culture wells were harvested by manual scraping and washed with media contained 10%FCS.  Cell pellets were incubated for 25 minutes with APC conjugated human anti-CD11c monoclonal antibody, followed by addition of propidium iodide to identify dead cells.  Cells were washed and resuspended in RPMI+10%FCS and then sorted using a FACSAria sorter to obtain the CD11c+PI- fraction, representing the viable MDDC.  5x10^5 sorted MDDC were lysed immediately in 500ul of Trizol and stored at -80°C prior to RNA extraction.

tag: CD14+ monocytes obtained from the peripheral blood of atopic adults

tag: Sample 4 Day 5 MDDC differentiated without AEC


title: Sample 5 control MDDC, day 5

description: Gene expression data from MDDC isolated after 5 days of IL-4/GM-CSF-induced differentiation in the absence of AEC

source_name: control MDDC, day 5

tag: Sample 5 Day 5 MDDC differentiated without AEC


title: 24h_Leuzea_2

city: Jena

first: Friedemann

last: Gaube

address: Semmelweisstr. 10

department: Pharmacy

country: Germany

institute: Friedrich-Schiller-University Jena

description:
Analysis of gene expression in MCF-7 cells after 24h stimulation with
a dichloromethane ASE-extract of Leuzea carthamoides DC.

scan_protocol: Standard Protocol: Affymetrix GeneChip expression Analysis Technical Manual, Version 701021, Rev. 4. Scanning was done using a GeneChip Scanner 3000 7G with default parameters.

data_processing: Initial data analysis was performed with Affymetrix MAS5.1 software, setting the scaling of all probe sets to a constant value of 500. Data were further normalized using RMAExpress sofware (release 0.4 alpha 7).

growth_protocol: cells were incubated in DMEM + 10% FCS for 24h before treatment

extract_protocol: Total RNA was extracted using RNeasy Mini Kit (QIAGEN) according to the manufacturers protocol. RNA quality was checked by UV spectroscopy and agarose (1.5 %) gel electrophoresis (EtBR staining)

treatment_protocol: MCF-7 were incubated for 24h with extracts/compounds in DMEM containing 10% hormone-free dextran-charcoal stripped FCS

tag: human breast adenocarcinoma epithelial cell line, ER+, derived from pleural effusion of a 69year-old caucasian woman


title: Sample 5 AEC-conditioned MDDC, day 5


title: Sample 4 control MDDC, day 5


title: Apex_5DAS_2

source_name: Arabidopsis thaliana vegetative apices, 7DAS

growth_protocol: Soil grown at short days

extract_protocol: Using qiagen RNAEasy kit, accoriding to manufacturer protocol


title: Sample 1 AEC-conditioned MDDC, day 5

tag: Sample 1 Day 5 MDDC differentiated without AEC


title: Sample 3 control MDDC, day 5

tag: Sample 3 Day 5 MDDC differentiated without AEC


title: Apex_5DAS_1

source_name: Arabidopsis thaliana vegetative apices, 7 DAS


title: Apex_Col_14DAS_2


title: 24h_Leuzea_1

hyb_protocol: Standard Protocol: Affymetrix GeneChip expression Analysis Technical Manual, Version 701021, Rev. 4


title: Sample 3 AEC-conditioned MDDC, day 5


title: Sample 2 AEC-conditioned MDDC, day 5

tag: Sample 2 Day 5 MDDC differentiated without AEC


title: Sample 2 control MDDC, day 5


title: Distal Colon at 8pm -rep a

status: Public on Sep 15 2008

city: Ann Arbor

first: Willemijntje

middle: A

last: Hoogerwerf

state: MI

address: 2215 Fuller Road

department: Internal Medicine

institute: VA Ann Arbor Healthcare System (111D)

description: Gene Expression data for distal colon at 8pm

hyb_protocol: Follow fragmentation, 10ug of cRNA were hybridized for 16 hrs at 45C on MOE 430 plus2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400

scan_protocol: Gene Array Scanner (Hewlett Packard) 3000

data_processing: The data were analyzed with GCOS using Affymetrix default analysis settings and global scaling

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 8pm

label_protocol: Biotinylated cRNA were prepared accordiing to the standard Affymetrix protocol from 8.4 ug of total RNA

growth_protocol: Distal Colonic tissue was collected every four hours, at 0400, 0800, 1200, 1600, 2000 and 2400

extract_protocol: Total RNA was isolated by modified guanidinium thicyanate-phenol-chloroform extraction method and was treated with DNase I (Promega, Madison, WI) at 37 C for 30 minutes.

tag: distal colon


title: Distal Colon at 4pm -rep b

description: Gene Expression data for distal colon at 4pm

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 4pm


title: Distal Colon at 12pm -rep c

description: Gene Expression data for distal colon at 12pm

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 12pm


title: Distal Colon at 8am -rep a

description: Gene Expression data for distal colon at 8am

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus 8am


title: Distal Colon at 4am -rep c

description: Gene Expression data for distal colon at 4am

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 4am


title: Distal Colon at 12pm -rep b


title: Distal Colon at 4pm -rep a


title: Sample 1 control MDDC, day 5


title: Distal Colon at 4pm -rep c


title: Distal Colon at 8pm -rep b


title: Distal Colon at 12am -rep b

description: Gene Expression data for distal colon at 12am

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 12am


title: Distal Colon at 8am -rep c

source_name: distal colon was identified following laparotomy, resected approximately 0.5 cm above the anus: 8am


title: Distal Colon at 12pm -rep a


title: Distal Colon at 12am -rep c


title: Distal Colon at 4am -rep a


title: Distal Colon at 4am -rep b


title: Distal Colon at 8pm -rep c


title: Distal Colon at 8am -rep b

source_name: distal colon was identified following laparotomy,resected approximately 0.5 cm above the anus: 8am


title: Distal Colon at 12am -rep a


title: HUVEC_TNFa_6h30m

status: Public on Sep 13 2008

city: Komaba

first: Shuichi

last: Tsutsumi

country: Japan

institute: The University of Tokyo

description: 6h30m after TNFa stimulation

hyb_protocol: 10 micrograms of fragmented cRNA were hybridised (45 degrees CelsiusC, 16 hours). Hybridization was controled by use of the GeneChip Eukaryotic Hybridization Control Kit (Affymetrix). Washing and staining was performed in a Fluidics Station 450 (Affymetrix) using the protocol EukGE-WS2v4.

scan_protocol: Scanning was performed in an Affymetrix GeneChip scanner 3000 7G.

data_processing: Affymetrix Microarray Suite v5.0 with target intensity=100

source_name: TNFa 6h30m

label_protocol: In vitro transcription was performed on 1 microgram of cDNA using the Enzo BioArray High Yield RNA transcript labelling kit (Enzo Diagnostics). The cRNA was cleaned using RNAeasy clean-up columns (Qiagen). The cRNA was fragmented by heating in 40 mM Tris-acetate pH 8.1, 100 mM KOAc, 30 mM MgOAc.

extract_protocol: Total RNAs were extracted using Isogen (Nippon Gene, Osaka, Japan). 3 micrograms of total RNA was reverse transcribed using the SuperScript III system for cDNA synthesis (Invitrogen) according to the protocol recommended by Affymetrix.

treatment_protocol: Human umbilical vein cells were serum-starved in EBM-2 (Clonetics) containing 0.5% FBS for 18 h, and then treated 10 ng/ml TNF-alpha (Peprotec) and samples collected after each time

tag: Hman umbilical vein cells


title: HUVEC_TNFa_7h00m

description: 7h00m after TNFa stimulation

source_name: TNFa 7h00m


title: HUVEC_TNFa_5h30m

description: 5h30m after TNFa stimulation

source_name: TNFa 5h30m


title: HUVEC_TNFa_6h00m

description: 6h00m after TNFa stimulation

source_name: TNFa 6h00m


title: HUVEC_TNFa_8h00m

description: 8h00m after TNFa stimulation

source_name: TNFa 8h00m


title: HUVEC_TNFa_0h00m

description: 0h00m after TNFa stimulation

source_name: TNFa 0h00m

extract_protocol: Total RNAs were extracted using Isogen (Nippon Gene, Osaka, Japan). 3 micrograms of total RNA was reverse transcribed using the SuperScript III system for cDNA synthesis (Invitrogen) according to the protocol recommended by Affymetrix. The oligonucleotide used for priming was 5'-ggccagtgaattgtaatacgactcactatagggaggcgg-(t)24-3' (Invitrogen). Double-stranded cDNA was cleaned by phenol:chloroform extraction and the aqueous phase removed by centrifugation through Phase-lock Gel (Eppendorf).


title: HUVEC_TNFa_2h15m

description: 2h15m after TNFa stimulation

source_name: TNFa 2h15m


title: HUVEC_TNFa_2h00m

description: 2h00m after TNFa stimulation

source_name: TNFa 2h00m


title: HUVEC_TNFa_3h30m

description: 3h30m after TNFa stimulation

source_name: TNFa 3h30m


title: HUVEC_TNFa_1h00m

description: 1h00m after TNFa stimulation

source_name: TNFa 1h00m


title: HUVEC_TNFa_4h30m

description: 4h30m after TNFa stimulation

source_name: TNFa 4h30m


title: HUVEC_TNFa_4h00m

description: 4h00m after TNFa stimulation

source_name: TNFa 4h00m


title: HUVEC_TNFa_0h15m

description: 0h15m after TNFa stimulation

source_name: TNFa 0h15m


title: HUVEC_TNFa_1h30m

description: 1h30m after TNFa stimulation

source_name: TNFa 1h30m


title: HUVEC_TNFa_7h30m

description: 7h30m after TNFa stimulation

source_name: TNFa 7h30m


title: HUVEC_TNFa_1h45m

description: 1h45m after TNFa stimulation

source_name: TNFa 1h45m


title: HUVEC_TNFa_3h15m

description: 3h15m after TNFa stimulation

source_name: TNFa 3h15m


title: HUVEC_TNFa_0h30m

description: 0h30m after TNFa stimulation

source_name: TNFa 0h30m


title: HhAntag 4 (430 2.0)

status: Public on Sep 12 2008

city: South San Francisco

first: Peter

last: Haverty

address: 1 DNA Way

department: Bioinformatics

institute: Genentech, Inc.

description: Human_murine xenograft

hyb_protocol: standard Affymetrix protocol

scan_protocol: standard Affymetrix protocol

data_processing: MAS 5

organism:
Homo sapiens
Mus musculus

source_name: pancreatic tumor xenograft, HhAntag treated, replicate 4

label_protocol: standard Affymetrix protocol

extract_protocol: standard Affymetrix protocol

tag: Pancreatic tumor


title: HUVEC_TNFa_2h30m

description: 2h30m after TNFa stimulation

source_name: TNFa 2h30m


title: HUVEC_TNFa_3h00m

description: 3h00m after TNFa stimulation

source_name: TNFa 3h00m


title: Vehicle 4 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, vehicle treated, replicate 4


title: HUVEC_TNFa_3h45m

description: 3h45m after TNFa stimulation

source_name: TNFa 3h45m


title: HUVEC_TNFa_1h15m

description: 1h15m after TNFa stimulation

source_name: TNFa 1h15m


title: HUVEC_TNFa_0h45m

description: 0h45m after TNFa stimulation

source_name: TNFa 0h45m


title: HhAntag 3 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, HhAntag treated, replicate 3


title: HhAntag 1 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, HhAntag treated, replicate 1


title: HUVEC_TNFa_2h45m

description: 2h45m after TNFa stimulation

source_name: TNFa 2h45m


title: HhAntag 2 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, HhAntag treated, replicate 2


title: Vehicle 3 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, vehicle treated, replicate 3


title: HhAntag 3 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 1 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, vehicle treated, replicate 1


title: HhAntag 1 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 3 (U133 Plus 2.0)

description: Human_murine xenograft


title: HhAntag 2 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 2 (430 2.0)

description: Human_murine xenograft

source_name: pancreatic tumor xenograft, vehicle treated, replicate 2


title: HhAntag 4 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 1 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 4 (U133 Plus 2.0)

description: Human_murine xenograft


title: Vehicle 2 (U133 Plus 2.0)

description: Human_murine xenograft


title: Rsl2 tg female, biological rep2

status: Public on Sep 10 2008

first: Christopher

middle: J

last: Krebs

address: 1241 E. Catherine St

department: Human Genetics

institute: University of Michigan Medical School

description:
Rsl2_tg_female_B
Gene expression data from total liver RNA

hyb_protocol: Following fragmentation, 5 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Mouse Genome 430 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.

data_processing: The data were analyzed with RMA and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1500.

source_name: Rsl2 tg female mouse liver RNA

label_protocol: Labeling, hybridization, scanning and data processing were performed by the University of Michigan Comprehensive Cancer Center Microarray Core facility (http://www.umich.edu/~caparray). Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: Mice were fed standard laboratory chow (Purina # 5001)

extract_protocol: Total RNA was isolated using guanidinium isothiocyanate and organic extraction according to Current Protocols in Molecular Biology, Vol. 1, Supplement 36.

tag: Genotype

value: B10.D2.PL (rsl/rsl), Rsl2-tg

tag: Sex

value: female


title: HUVEC_TNFa_5h00m

description: 5h00m after TNFa stimulation

source_name: TNFa 5h00m


title: rsl female, biological rep2

description:
rsl_female_B
Gene expression data from total liver RNA

source_name: rsl female mouse liver RNA

value: B10.D2.PL (rsl/rsl)


title: Rsl2 tg male, biological rep2

description:
Rsl2_tg_male_B
Gene expression data from total liver RNA

source_name: Rsl2 tg male mouse liver RNA

value: male


title: control_rep2

city: Boston

first: Ramnik

last: Xavier

state: MA

address: 185 Cambridge Street, 7th Floor

institute: Massachusetts General Hospital

description: The aim of this study is to survey global gene expression of total thymocytes from wild-type mice and Atg16l1 mutant (hypomorph) mice.

hyb_protocol: Standard Affymetrix protocol

scan_protocol: Standard Affymetrix protocol

data_processing: Standard Affymetrix GCOS data processing

source_name: control, rep2

label_protocol: Affymetrix GeneChip expression labeling protocol

extract_protocol: RNeasy mini kit (Qiagen)

tag: female thymus (7 weeks), control


title: Rsl2 tg male, biological rep1

description:
Rsl2_tg_male_A
Gene expression data from total liver RNA


title: wt female, biological rep2

description:
Wild_Type_female_B
Gene expression data from total liver RNA

source_name: Wild type female mouse liver RNA

value: B10.D2 (Rsl/Rsl)


title: Rsl1 tg male, biological rep2

description:
Rsl1_tg_male_B
Gene expression data from total liver RNA

source_name: Rsl1 tg male mouse liver RNA

value: B10.D2.PL (rsl/rsl), Rsl1-tg


title: Rsl1 tg female, biological rep2

description:
Rsl1_tg_female_B
Gene expression data from total liver RNA

source_name: Rsl1 tg female mouse liver RNA


title: Rsl1 tg female, biological rep1

description:
Rsl1_tg_female_A
Gene expression data from total liver RNA


title: control_rep1

source_name: control, rep1

tag: male thymus (7 weeks), control


title: rsl male, biological rep1

description:
rsl_male_A
Gene expression data from total liver RNA

source_name: rsl male mouse liver RNA


title: hypomorph_rep2

source_name: hypomorph, rep2

tag: female thymus (7 weeks), Atg16l1 hypomorph


title: rsl female, biological rep1

description:
rsl_female_A
Gene expression data from total liver RNA


title: hypomorph_rep1

source_name: hypomorph, rep1

tag: male thymus (7 weeks), Atg16l1 hypomorph


title: wt male, biological rep2

description:
Wild_Type_male_B
Gene expression data from total liver RNA

source_name: Wild type male mouse liver RNA


title: Rsl1 tg male, biological rep1

description:
Rsl1_tg_male_A
Gene expression data from total liver RNA


title: Rsl2 tg female, biological rep1

description:
Rsl2_tg_female_A
Gene expression data from total liver RNA


title: wt male, biological rep1

description:
Wild_Type_male_A
Gene expression data from total liver RNA


title: rsl male, biological rep2

description:
rsl_male_B
Gene expression data from total liver RNA


title: wt female, biological rep1

description:
Wild_Type_female_A
Gene expression data from total liver RNA


title: HT29 sensitive cells replicate 3

status: Public on Sep 08 2008

city: Barcelona

first: Carlos

last: Ciudad

state: Barcelona

address: Av. Juan XXIII-27

department: Biochemistry and Molecular Biology

country: Spain

institute: University of Barcelona

description: Gene expression profile of HT29 cells sensitive to Methotrexate.

hyb_protocol: Affymetrix protocol for HG U133 plus 2.0

data_processing: Value generated using MAS 5.0 non-scaled

source_name: HT29 methotrexate-sensitive cells

extract_protocol: RNeasy Mini Kit from Qiagen

tag: cell line

tag: cell type

value: colon cancer

tag: methotrexate sensitivity

value: sensitive


title: HT29 sensitive cells replicate 2

scan_protocol: Affymetrix protocol for HG U133 plus 2.0


title: HT29 resistant cells replicate 2

description: Gene expression profile of HT29 cells resistant to Methotrexate.

source_name: HT29 methotrexate-resistant cells

label_protocol: Affymetrix protocol for HG U133 plus 2.0

value: resistant


title: HT29 resistant cells replicate 1


title: Arabidopsis growing pollen tubes rep2

city: Beijing

first: Wei-Hua

last: Wu

state: Beijing

address: No.2 Yuanmingyuan West Road

department: College of Biological Sciences

country: China

institute: China Agricultural University

description: In order to get enough pollen tubes, the “thin liquid layer” germination methods were developed.  First, the freshly anther-dehisced flowers were collected into 1.5 ml microfuge tubes filled with 800 ul of basic medium (the basic medium was composed of 1 mM KCl, 5 mM CaCl2, 0.8 mM MgSO4, 1.5 mM boric acid, 15% (w/v) sucrose, 0.05% (w/v) lactalbumin hgdrolysate, 10 uM myo-inositol, 5 mM MES, and the pH was adjusted to 5.8 with Tris).  The microfuge tubes were strongly vortexed for 2 min to release the mature pollen grains into the medium.  The mixture was then transferred into new microfuge tubes and centrifuged at 11,000 rpm for 1 min.  The pollen pellet was resuspended with 30 ul of the basic medium and subsequently cultured in the Petri dishes.  It was noticed that making a well-spreaded thin layer of pollen grains is a key point to get high rates (70%-75%) of pollen germination.  In order to well spread the tiny drop of pollen grains on the Petri dish (35 mm diameter) surface, a steel-wire net (D=80 um) was placed to form a thin liquid layer.  Then, the covered Petri dishes were transferred to a chamber and incubated at 25℃.  For the collection of the pollen tube samples, the pollen grains were incubated for 4 h, which resulted in an averaged pollen tube length about 150 um.  After removing the steel-wire net, the culture mixture was collected and filtered through 50 um nylon mesh to remove the ungerminated pollen grains.  The pollen tube samples were collected from the nylon mesh for total RNA extraction.

hyb_protocol: Fifteen ug of fragmented cRNA was added in 300 ul hybridization solutions and 200 ul of this mixture was used for hybridization on Arabidopsis ATH1 Genome Arrays for 16 h at 45 ℃.  The standard wash and double-stain protocols (EukGE-WS2v5-450) were applied using an Affymetrix GeneChip Fluidics Station 450.

scan_protocol: The arrays were scanned on an Affymetrix GeneChip scanner 3000. The scanned arrays were analyzed with Affymetrix GCOS 1.0 (MAS 5.0) software to generate both the CEL and CHP files.

data_processing: To ensure the reproducibility and reliability, two biological replicates were conducted and the RNAs that were used for microarray experiments were extracted from two independent plant populations.  The scanned arrays were analyzed first with Affymetrix GCOS 1.0 (MAS 5.0) software to generate detection calls.  All the 6 datasets (3 different samples from two biological replicates) were normalized using Affymetrix GCOS software, and the TGT value was set to 100.

source_name: Growing pollen tubes

label_protocol: Eight ug of purified total RNA was used to generate first-strand cDNA in a reverse transcription reaction (One-Cycle Target Labeling and Control Reagents, Affymetrix).  After second-strand synthesis, the double-stranded cDNA were used to generate cRNA via in vitro transcriptional reaction.  The cRNA was labeled with biotin and 20 ug of this cRNA was fragmented.  Size distribution of the cRNA and fragmented cRNA was assessed using an Eppendorf Biophotometer (Eppendorf) and electrophoresis.

growth_protocol: Arabidopsis thaliana (ecotype Columbia) plants were grown in mixed soil in a growth chamber.  The light intensity was 120-150 umol m-2 s-1 for a 16 h daily light period and day/night temperatures were 22℃±2℃ and 18℃±2℃, respectively.  Plants were watered once every 5 days with tap water and the relative humidity in the growth chamber was kept near 70%.

extract_protocol: The total RNA was extracted using the TRIzol reagent (Invitrogen).  RNA concentration, purity and integrity were determined and confirmed by using an Eppendorf Biophotometer (Eppendorf) and electrophoresis.  The total RNA was further purified using RNeasy Mini Kit (Qiagen).

tag: Ecotype

value: Arabidopsis thaliana (Columbia)

tag: Age

value: 50 days

tag: Tissue

value: growing pollen tubes


title: Arabidopsis desiccated mature pollen grains rep2

description: The desiccated mature pollen grains were collected from freshly anther-dehisced flowers using a vacuum machine as described by Johnson-Brousseau (2004).  (Johnson-Brousseau SA, McCormick S: A compendium of methods useful for characterizing Arabidopsis pollen mutants and gametophytically-expressed genes. Plant J 2004, 39:761-775.)

source_name: Desiccated mature pollen grains

value: desiccated mature pollen grains


title: Arabidopsis hydrated pollen grains rep2

description: In order to get enough hydrated pollen grains, the “thin liquid layer” germination methods were developed.  First, the freshly anther-dehisced flowers were collected into 1.5 ml microfuge tubes filled with 800 ul of basic medium (the basic medium was composed of 1 mM KCl, 5 mM CaCl2, 0.8 mM MgSO4, 1.5 mM boric acid, 15% (w/v) sucrose, 0.05% (w/v) lactalbumin hgdrolysate, 10 uM myo-inositol, 5 mM MES, and the pH was adjusted to 5.8 with Tris).  The microfuge tubes were strongly vortexed for 2 min to release the mature pollen grains into the medium.  The mixture was then transferred into new microfuge tubes and centrifuged at 11,000 rpm for 1 min.  The pollen pellet was resuspended with 30 ul of the basic medium and subsequently cultured in the Petri dishes.  It was noticed that making a well-spreaded thin layer of pollen grains is a key point to get high rates (70%-75%) of pollen germination.  In order to well spread the tiny drop of pollen grains on the Petri dish (35 mm diameter) surface, a steel-wire net (D=80 um) was placed to form a thin liquid layer.  Then, the covered Petri dishes were transferred to a chamber and incubated at 25℃ for 45 min and the hydrated pollen grains were collected for total RNA extraction.

source_name: Hydrated pollen grains

value: hydrated pollen grains


title: Arabidopsis growing pollen tubes rep1


title: HT29 sensitive cells replicate 1


title: Arabidopsis desiccated mature pollen grains rep1


title: HT29 resistant cells replicate 3


title: Arabidopsis hydrated pollen grains rep1


title: PMNs_normal_bone_marrow_4

status: Public on Sep 06 2008

city: St Louis

first: Jacqueline

last: Payton

state: MO

address: 4320 Forest Park Avenue, Suite 211

institute: Washington University School of Medicine

description: To better understand the pathogenesis of acute promyelocytic leukemia (APL, FAB M3 AML), we identified genes that are expressed differently in APL cells compared to other acute myeloid leukemia subtypes, and to normal promyelocytes.

hyb_protocol: Affymetrix standard

scan_protocol: Affymetrix standard

data_processing: Affymetrix MAS 5 algorithm, signal scaled to an array mean of 1500

source_name: PMNs (neutrophils) sorted from normal human bone marrow

label_protocol: Affymetrix standard

treatment_protocol: High-speed cell sorting was performed to isolate CD9-, CD14-, CD15hi, CD16hi neutrophils (PMNs).

tag: Adult normal healthy volunteer


title: Promyelocytes_normal_bone_marrow_5

source_name: Promyelocytes sorted from normal human bone marrow

treatment_protocol: High-speed cell sorting was then performed to isolate CD9-, CD14-, CD15hi, CD16lo promyelocytes.


title: Promyelocytes_normal_bone_marrow_2

treatment_protocol: High-speed cell sorting was performed to isolate CD9-, CD14-, CD15hi, CD16lo promyelocytes.


title: PR9_0HR_2

source_name: PR-9 cells, resting (no Zinc induction)

growth_protocol: All cell lines were maintained in RPMI 1640 supplemented with 10% fetal calf serum

tag: PR9 cell line


title: PMNs_normal_bone_marrow_5


title: PR9_Zn_16HR_2

source_name: PR9 cells, Zinc-induced, 16hrs

growth_protocol: All cell lines were maintained in RPMI 1640 supplemented with 10% fetal calf serum.

extract_protocol: Trizol reagent

treatment_protocol: PR-9 cells were induced in 100 microM ZnSO4 diluted in media.


title: Promyelocytes_normal_bone_marrow_3


title: Promyelocytes_normal_bone_marrow_4


title: PR9_Zn_4HR_2

source_name: PR-9 cells, Zinc-induced, 4hrs

treatment_protocol: 4 hour timepoint after Zinc induction (100 micromolar ZnSO4 diluted in media) of PML-RARA


title: Promyelocytes_normal_bone_marrow_1


title: PMNs_normal_bone_marrow_3

treatment_protocol: High-speed cell sorting was then performed to isolate and CD9-, CD14-, CD15hi, CD16hi neutrophils.


title: PR9_Zn_2HR_1

source_name: PR-9 cells, Zinc-induced, 2hrs

treatment_protocol: 2 hour timepoint after Zinc induction (100 micromolar ZnSO4 diluted in media) of PML-RARA


title: CD34+cells_normal_bone_marrow_4

source_name: CD34+ cells sorted from normal human bone marrow

treatment_protocol: MACS sorting was performed after incubation with anti-CD34 antibodies according to manufacturer’s instructions (Miltenyi Biotec, Auburn, CA).


title: PR9_0HR_1


title: CD34+cells_normal_bone_marrow_3


title: NB4cells_3

source_name: NB4 cell line

tag: NB4 cell line


title: PR9_Zn_4HR_1

source_name: PR-9 cells, Zinc-induced, 4 hrs


title: PR9_Zn_2HR_2


title: NB4cells_1


title: NB4cells_2


title: PR9_Zn_8hrs_2

source_name: PR-9 cells, Zinc-induced, 8hrs

treatment_protocol: 8 hour timepoint after Zinc induction (100 micromolar ZnSO4 diluted in media) of PML-RARA


title: PR9_Zn_24HR_2

source_name: PR9 cell line, Zinc-induced, 24 hrs

treatment_protocol: 24 hour timepoint after Zinc induction (100 micromolar ZnSO4 diluted in media) of PML-RARA


title: PR9_Zn_16HR_1

source_name: PR-9 cells, Zinc-induced, 16hrs

treatment_protocol: 16 hour timepoint after Zinc induction (100 micromolar ZnSO4 diluted in media) of PML-RARA


title: PMNs_normal_bone_marrow_1


title: PR9_Zn_24HR_1

source_name: PR9 cell line, Zinc-induced, 24hrs


title: PMNs_normal_bone_marrow_2


title: CD34+cells_normal_bone_marrow_1


title: PR9_Zn_8hrs_1


title: CD34+cells_normal_bone_marrow_2


title: SL2-GST-replicate1

status: Public on Sep 05 2008

city: Martinsried

first: Tobias

last: Straub

address: Großhadener Str. 9

department: Biomedical Center, Bioinformatics

institute: LMU Munich

hyb_protocol: Hybridization was performed by ImaGenes (http://www.imagenes-bio.de)

scan_protocol: Scanning was performed by ImaGenes (http://www.imagenes-bio.de)

data_processing: Raw data was processed using R/Bioconductor. Normalization and probeset expression values were calculated using GCRMA.

organism: Drosophila melanogaster

source_name: SL2 cell line

label_protocol: RNA labelling was performed by ImaGenes (http://www.imagenes-bio.de)

growth_protocol: Cells were grown in 6-well plates in Schneider Medium supplemented with 10% FCS, penicillin and streptomycin.

extract_protocol: Total RNA was extracted using Qiagen RNAEasy Mini kits including Qiagen DNAse on-column digestion according to manufacturer's instructions.

treatment_protocol: 1x10e6 cells were incubated with 10 µg dsRNA in serum-free medium for 1 hours. Serum-containing medium was added and cells were harvested after 7 days without further passaging.

tag: cells treated with GST dsRNA


title: SL2-ISWI-replicate2

tag: cells treated with ISWI dsRNA


title: SL2-GST-replicate2


title: SL2-ISWI-replicate3


title: SL2-GST-replicate3


title: 22106

first: Rekha

last: Meyer

address: 4320 Forest Park Av

hyb_protocol: Chips hybridized according to Manufacturer's protocol

data_processing: Data corrected to 1500 Baseline

source_name: Lung

label_protocol: Chips labeled with biotin according to Manufacturer's protocol

growth_protocol: Specimen from Primary Human Lung Tumor

extract_protocol: RNA extracted with Trizol

treatment_protocol: No treatment. Disease state only

tag: Race

value: White

tag: Gender

value: M

tag: TSP_Patient# 24341

value: Not Available

tag: Pathology

value: Adenocarcinoma


title: 22077

value: F

tag: TSP_Patient# 24302


title: 22105

value: African American

tag: TSP_Patient# 24340

value: Never


title: 22107

tag: TSP_Patient# 24342


title: 22144

tag: TSP_Patient# 24330


title: 22100

tag: TSP_Patient# 11974

value: Former


title: 22096

tag: TSP_Patient# 24329


title: 22101

tag: TSP_Patient# 24335


title: 22099

tag: TSP_Patient# 24333


title: 22103

tag: TSP_Patient# 24338


title: 22094

tag: TSP_Patient# 24327


title: SL2-ISWI-replicate1


title: 22102

tag: TSP_Patient# 24337


title: 22088

tag: TSP_Patient# 24320


title: 22095

tag: TSP_Patient# 24328


title: 22104

tag: Race

tag: TSP_Patient# 24339


title: 22086

tag: Gender

tag: TSP_Patient# 24318


title: 22090

tag: TSP_Patient# 24323

tag: Pathology

value: Other


title: 22092

tag: TSP_Patient# 24325


title: 22091

tag: TSP_Patient# 24324


title: 22083

tag: TSP_Patient# 24314


title: 22097

tag: TSP_Patient# 24331

value: Current


title: 22087

tag: TSP_Patient# 24319


title: 22089

tag: TSP_Patient# 24321

value: Large cell Neuroendocrine carcinoma


title: 22085

tag: TSP_Patient# 24317


title: CD34+cells_normal_bone_marrow_5

tag: Adult normal healthy volunteer


title: 22082

tag: TSP_Patient# 24313


title: 22076

tag: TSP_Patient# 24301


title: 22084

tag: TSP_Patient# 24316


title: 22081

tag: Race

tag: TSP_Patient# 24312


title: 22075

tag: Gender

tag: TSP_Patient# 24300


title: 22080

tag: TSP_Patient# 24311


title: 22078

tag: TSP_Patient# 24303

tag: Pathology


title: 22072

tag: TSP_Patient# 24297


title: 22073

tag: TSP_Patient# 24298


title: 22074

tag: TSP_Patient# 24299


title: 22079

tag: TSP_Patient# 24304


title: 22067

tag: TSP_Patient# 24292


title: 22069

tag: TSP_Patient# 24294


title: 22065

tag: TSP_Patient# 24290

value: Sqaumous cell carcinoma


title: 22070

tag: TSP_Patient# 24295


title: 22068

tag: TSP_Patient# 24293


title: 22047

tag: TSP_Patient# 24268


title: 22046

tag: Race

tag: TSP_Patient# 24267


title: 22048

tag: Gender

tag: TSP_Patient# 24269


title: 22040

tag: TSP_Patient# 24258


title: 22041

tag: TSP_Patient# 24259


title: 22038

tag: TSP_Patient# 24255

tag: Pathology


title: 22071

tag: TSP_Patient# 24296


title: 22066

tag: TSP_Patient# 24291


title: 22045

tag: TSP_Patient# 24266


title: 22093

tag: TSP_Patient# 24326


title: 22039

tag: TSP_Patient# 24256


title: 22042

tag: TSP_Patient# 24261


title: 22043

tag: TSP_Patient# 24263


title: 22037

tag: TSP_Patient# 24252


title: 22036

tag: TSP_Patient# 24251


title: 22044

tag: Race

tag: TSP_Patient# 24265


title: 22059

tag: Gender

tag: TSP_Patient# 24283


title: 22054

tag: TSP_Patient# 24276


title: 22058

tag: TSP_Patient# 24282


title: 22035

tag: TSP_Patient# 24250


title: 22033

tag: TSP_Patient# 24248

tag: Pathology


title: 22062

tag: TSP_Patient# 24287


title: 22051

tag: TSP_Patient# 24272


title: 22034

tag: TSP_Patient# 24249


title: 22050

tag: TSP_Patient# 24271


title: 22060

tag: TSP_Patient# 24284


title: 22064

tag: TSP_Patient# 24289


title: 22056

tag: TSP_Patient# 24279


title: 22049

tag: TSP_Patient# 24270


title: 22055

tag: Race

tag: TSP_Patient# 24278


title: 22052

tag: Gender

tag: TSP_Patient# 24273


title: 22053

tag: TSP_Patient# 24275


title: 22061

tag: TSP_Patient# 24286


title: MCF-7 RNA (10ug/ml alpha-amanitin)

city: Taipei

first: Ming-Ta

last: Hsu

address: No.155, Sec.2, Linong Street

country: Taiwan

institute: National Yang Ming University

description:
Array Image: Without seriously artifacts
Background: 20-100
Noise: <10
Hybridization controls: BioB: 50%A; 50%P
bioC, bioD, and cre: P
internal control genes: Either 3'/5' probe set of GAPDH or 3'/5' probe set of actin <3

hyb_protocol: Affymetrix microarray was performed using Human U133 2.0 (Affymetrix). Details of the methods for RNA quality, sample labeling, hybridization and expression analysis are according to the manual of Affymetrix Microarray Kit and Affymetrix website.

data_processing: Using scaling factor. The default settings are "scaling all probe sets to target signal: 500" and "normalization by user defined in value: 1

source_name: MCF7 cell line (with 10μg/ml alpha-amanitin treatment for 48hrs)

extract_protocol: Cells were grown to 85 % confluence in 10 cm tissue culture dish. Cells were treated with 10μg/ml of alpha-amanitin for 48hrs. Each 10 cm dish was washed with 1x PBS for three times. Total RNA was extracted according to the RNeasy® Mini Kit Spin Protocol (QIAGEN). The integrity of the RNA extract was checked by 1.2 % (w/v) agarose gel electrophoresis and the concentration of RNA was estimated by ultraviolet spectrophotometry.

tag: Cell line

value: Female

tag: Age

tag: Tissue

value: Breast tumor


title: human cultured bladder IC DM, subject 10

city: Lexington

first: Deborah

last: Erickson

state: KY

address: 800 Rose Street, MS275

department: Surgery

institute: University of Kentucky

description: Evaluate gene expression profiles after inducing differentiation in cultured interstitial cystitis (IC) and control urothelial cells.

hyb_protocol: Standard Affimetrix

scan_protocol: Affy

data_processing: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 500.

label: Standard Affymetrix

source_name: human

label_protocol: Standard Affymetrix

growth_protocol: The initial growth medium (KM) was according to Southgate: Keratinocyte Growth Medium with 5 ng/ml recombinant human epidermal growth factor (EGF), 50 ?g/ml bovine pituitary extract (all from Gibco) and 30 ng/ml cholera toxin (Sigma, St. Louis, MO).  To induce differentiation, medium was changed two days before extraction to a high-calcium, serum-containing medium (DM) described by Keay:  DMEM-F12 (Media Tech, Herndon, VA) with 10% fetal bovine serum , 1% antibiotic/antimycotic solution, 1% L-glutamine, 1.0 U/ml insulin (all from Sigma), and 5 ?g/ml hEGF (R & D Systems, Minneapolis, MN). Total RNA was extracted from cells at passages 3 to 6.

extract_protocol: Standard Affymetrix

treatment_protocol: A single cold-cup bladder biopsy was taken and transported immediately to the laboratory in growth medium.  Each biopsy was divided into 6-10 pieces using fine scissors and optical loupes.  The pieces were distributed into a 6-well plate with 1-2 pieces per well.  1.5 ml growth medium was added to each well and the plate was incubated at 37oC, 5% carbon dioxide.  Additional medium was added to the wells on day 3, and a schedule of changing medium three times a week was started on day 5.  When the epithelial cells had grown from the primary explants, they were passaged using TrypLE Express (Gibco, Invitrogen Corporation, Carlsbad, CA) according to the manufacturer’s instructions and re-seeded into the appropriate size vessel for a 2500 cells/cm2 density.

tag: Female, age 39

tag: Disease status

value: IC (interstitial cystitis)

tag: Culture medium

value: DM (differentiating medium)


title: human cultured bladder IC DM, subject 1

tag: Female, age 29


title: human cultured bladder IC DM, subject 3

tag: Female, age 37


title: human cultured bladder HB KM, subject 12

growth_protocol: Growth medium (KM) was according to Southgate: Keratinocyte Growth Medium with 5 ng/ml recombinant human epidermal growth factor (EGF), 50 ?g/ml bovine pituitary extract (all from Gibco) and 30 ng/ml cholera toxin (Sigma, St. Louis, MO).  Total RNA was extracted from cells at passages 3 to 6.

tag: Female, age 57

value: HB (control (stress incontinence, no bladder pain))

value: KM (proliferating medium)


title: human cultured bladder IC KM, subject 3


title: human cultured bladder IC KM, subject 1


title: human cultured bladder IC KM, subject 10


title: human cultured bladder HB KM, subject 13

tag: Female, age 56


title: human cultured bladder HB DM, subject 13


title: human cultured bladder HB DM, subject 12


title: human cultured bladder HB DM, subject 8

tag: Female, age 47


title: 1053 - mAdbID:70399

status: Public on Sep 04 2008

city: Bethesda

first: Louis

middle: M.

last: Staudt

address: 9000 Rockville Pike, Bldg 10, Rm 4N114

department: Lymphoid Malignancies Branch

institute: National Cancer Institute

description: mAdb experiment ID: 70399

hyb_protocol: Affymetrix Hybridization Protocol Other: Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: Affy Scanning Protocol Other: Scanning was performed by the Affymetrix 3000 Scanner.

data_processing:
MAS 5.0 Data Processing Protocol
Calculation Method: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 500.

label_protocol:
Affymetrix Labeling Protocol
Other: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 microg mRNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol:
Sample RNA Extraction Protocol
Other: Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.

value: female

value: lymph node

tag: Disease state

value: Lymphoma

tag: Individual

tag: Clinical info

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:PMBL

value: Follow up status:DEAD

value: Follow up years:1.04

value: ECOG performance status:NA

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 1949 - mAdbID:69359

description: mAdb experiment ID: 69359

tag: Gender

value: male

value: Follow up status:ALIVE

value: Follow up years:4.27


title: 1920 - mAdbID:69962

description: mAdb experiment ID: 69962

value: Follow up years:1.97


title: 1990 - mAdbID:74491

description: mAdb experiment ID: 74491

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:0.06


title: human cultured bladder HB KM, subject 8

value: HB (control (stress incontinence, no bladder pain))

value: KM (proliferating medium)


title: 824 - mAdbID:68986

description: mAdb experiment ID: 68986

value: lymph node

value: Follow up years:12.23


title: 546 - mAdbID:70400

description: mAdb experiment ID: 70400

value: female

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up years:0.77


title: 2018 - mAdbID:75131

description: mAdb experiment ID: 75131

value: Follow up status:DEAD

value: Follow up years:0.16

value: ECOG performance status:NA


title: 791 - mAdbID:68949

description: mAdb experiment ID: 68949

value: Final microarray diagnosis:PMBL

value: Follow up years:1.32

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 998 - mAdbID:70394

description: mAdb experiment ID: 70394

value: male

value: Follow up status:ALIVE

value: Follow up years:9.10


title: 1024 - mAdbID:70397

description: mAdb experiment ID: 70397

value: Follow up years:19.83


title: 2095 - mAdbID:74494

description: mAdb experiment ID: 74494

value: lymph node

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:0.96


title: 638 - mAdbID:70401

description: mAdb experiment ID: 70401

value: Lymphoma

value: Follow up years:0.69


title: 994 - mAdbID:68950

description: mAdb experiment ID: 68950

value: Submitting diagnosis:DLBCL

value: Follow up years:4.78


title: 439 - mAdbID:69959

description: mAdb experiment ID: 69959

value: Follow up status:NA

value: Follow up years:NA


title: 1946 - mAdbID:69961

description: mAdb experiment ID: 69961

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:0.68

value: ECOG performance status:NA


title: 1993 - mAdbID:69360

description: mAdb experiment ID: 69360

value: female

value: Final microarray diagnosis:PMBL

value: Follow up years:1.32

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 1924 - mAdbID:68951

description: mAdb experiment ID: 68951

value: lymph node

value: Follow up status:ALIVE

value: Follow up years:6.11


title: 2020 - mAdbID:69960

description: mAdb experiment ID: 69960

value: male

value: Lymphoma

value: Follow up years:2.07


title: 1006 - mAdbID:70395

description: mAdb experiment ID: 70395

value: Submitting diagnosis:DLBCL

value: Follow up years:7.11


title: 1994 - mAdbID:74493

description: mAdb experiment ID: 74493

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:1.20


title: 2001 - mAdbID:75130

description: mAdb experiment ID: 75130

value: Follow up status:DEAD

value: Follow up years:1.31


title: 2002 - mAdbID:66617

description: mAdb experiment ID: 66617

value: female

value: Follow up years:6.62

value: ECOG performance status:NA


title: 1991 - mAdbID:74492

description: mAdb experiment ID: 74492

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:1.00

value: LDH ratio:NA


title: 1992 - mAdbID:66618

description: mAdb experiment ID: 66618

value: lymph node

value: Final microarray diagnosis:PMBL

value: Follow up years:0.99

value: Number of extranodal sites:NA


title: 691 - mAdbID:68948

description: mAdb experiment ID: 68948

value: male

value: Lymphoma

value: Follow up years:0.32


title: 1942 - mAdbID:66615

description: mAdb experiment ID: 66615

value: Submitting diagnosis:DLBCL

value: Follow up status:ALIVE

value: Follow up years:0.87


title: 1989 - mAdbID:66616

description: mAdb experiment ID: 66616

value: Follow up status:NA

value: Follow up years:NA


title: 2092 - mAdbID:66614

description: mAdb experiment ID: 66614

value: Follow up years:1.27


title: 22057

tag: Race

value: African American

value: F

tag: TSP_Patient# 24280

value: Current

tag: Pathology

value: Adenocarcinoma


title: 1948 - mAdbID:66612

description: mAdb experiment ID: 66612

value: female

tag: Age

value: lymph node

value: Follow up years:7.95

value: ECOG performance status:NA

value: LDH ratio:NA


title: 2019 - mAdbID:66613

description: mAdb experiment ID: 66613

value: male

tag: Tissue

value: Lymphoma

value: Final microarray diagnosis:PMBL

value: Follow up status:DEAD

value: Follow up years:0.99

value: Number of extranodal sites:NA


title: 22063

value: White

tag: TSP_Patient# 24288

value: Former


title: 1943 - mAdbID:66611

description: mAdb experiment ID: 66611

value: Submitting diagnosis:DLBCL

value: Follow up status:ALIVE

value: Follow up years:8.96


title: 1001 - mAdbID:74485

description: mAdb experiment ID: 74485

extract_protocol:
Sample Extraction Protocol
Other: Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:0.33

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:0.96

value: Number of extranodal sites:0


title: 854 - mAdbID:74482

description: mAdb experiment ID: 74482

value: male

value: lymph node

value: Follow up years:1.51

value: ECOG performance status:1

value: LDH ratio:0.82

value: Number of extranodal sites:1


title: 1018 - mAdbID:74488

description: mAdb experiment ID: 74488

value: Lymphoma

value: Follow up status:DEAD

value: Follow up years:0.03

value: LDH ratio:5.68


title: 1941 - mAdbID:66610

description: mAdb experiment ID: 66610

value: female

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:PMBL

value: Follow up status:ALIVE

value: Follow up years:0.70

value: ECOG performance status:NA

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 856 - mAdbID:74484

description: mAdb experiment ID: 74484

value: male

value: lymph node

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:0.6

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:1.17

value: Number of extranodal sites:0


title: 777 - mAdbID:66369

description: mAdb experiment ID: 66369

value: Lymphoma

value: Follow up status:DEAD

value: Follow up years:4.27


title: 838 - mAdbID:74481

description: mAdb experiment ID: 74481

value: Submitting diagnosis:DLBCL

value: Follow up years:0


title: 1923 - mAdbID:66608

description: mAdb experiment ID: 66608

value: female

value: Final microarray diagnosis:PMBL

value: Follow up status:ALIVE

value: Follow up years:1.59


title: 789 - mAdbID:66370

description: mAdb experiment ID: 66370

value: male

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:NA

value: Follow up years:NA

value: ECOG performance status:NA

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 808 - mAdbID:74478

description: mAdb experiment ID: 74478

value: lymph node

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:0.37

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:0.05

value: Number of extranodal sites:0


title: 855 - mAdbID:74483

description: mAdb experiment ID: 74483

value: female

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up years:1.67

value: ECOG performance status:1

value: LDH ratio:1.2


title: 1935 - mAdbID:66609

description: mAdb experiment ID: 66609

value: Final microarray diagnosis:PMBL

value: Follow up status:ALIVE

value: Follow up years:12.41


title: 621 - mAdbID:66606

description: mAdb experiment ID: 66606

value: male

value: Follow up years:8.14

value: ECOG performance status:NA

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 570 - mAdbID:66605

description: mAdb experiment ID: 66605

value: lymph node

value: Follow up years:14.39


title: 1054 - mAdbID:74489

description: mAdb experiment ID: 74489

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:12.34

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:0.52

value: Number of extranodal sites:0


title: 751 - mAdbID:74477

description: mAdb experiment ID: 74477

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up years:9.99

value: ECOG performance status:0

value: LDH ratio:0.72


title: 1007 - mAdbID:74487

description: mAdb experiment ID: 74487

value: female

value: Follow up status:DEAD

value: Follow up years:2.26

value: ECOG performance status:2

value: LDH ratio:1.01


title: 484 - mAdbID:66604

description: mAdb experiment ID: 66604

value: male

value: lymph node

value: Final microarray diagnosis:PMBL

value: Follow up years:1.39

value: ECOG performance status:NA

value: LDH ratio:NA

value: Number of extranodal sites:NA


title: 831 - mAdbID:74479

description: mAdb experiment ID: 74479

value: Lymphoma

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:11.02

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:1.41

value: Number of extranodal sites:0


title: 1921 - mAdbID:66607

description: mAdb experiment ID: 66607

value: female

value: Submitting diagnosis:DLBCL

value: Follow up status:ALIVE

value: Follow up years:4.15


title: 684 - mAdbID:74475

description: mAdb experiment ID: 74475

value: male

value: lymph node

value: Follow up status:DEAD

value: Follow up years:1.92

value: ECOG performance status:2

value: LDH ratio:1.19


title: 1041 - mAdbID:74490

description: mAdb experiment ID: 74490

value: Lymphoma

value: Follow up years:3.13

value: Number of extranodal sites:1


title: 834 - mAdbID:74480

description: mAdb experiment ID: 74480

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:1.64

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:NA

value: LDH ratio:0.8


title: 682 - mAdbID:73847

description: mAdb experiment ID: 73847

value: Submitting diagnosis:DLBCL

value: Follow up years:0.11

value: ECOG performance status:1

value: LDH ratio:NA

value: Number of extranodal sites:0


title: 671 - mAdbID:73848

description: mAdb experiment ID: 73848

value: male

value: lymph node

value: Follow up status:ALIVE

value: Follow up years:3.35

value: LDH ratio:0.74


title: 748 - mAdbID:74476

description: mAdb experiment ID: 74476

value: female

value: Lymphoma

value: Follow up status:DEAD

value: Follow up years:1.01

value: LDH ratio:2.38


title: 625 - mAdbID:73845

description: mAdb experiment ID: 73845

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:5.24

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:0

value: LDH ratio:0.88


title: 664 - mAdbID:73846

description: mAdb experiment ID: 73846

value: Submitting diagnosis:DLBCL

value: Follow up years:0.62

value: ECOG performance status:2

value: LDH ratio:1.05


title: 491 - mAdbID:73842

description: mAdb experiment ID: 73842

value: lymph node

value: Follow up years:4.47

value: ECOG performance status:3

value: Number of extranodal sites:0


title: 1004 - mAdbID:74486

description: mAdb experiment ID: 74486

value: female

value: Lymphoma

value: Follow up status:ALIVE

value: Follow up years:6.72

value: ECOG performance status:1

value: LDH ratio:0.62


title: 615 - mAdbID:73844

description: mAdb experiment ID: 73844

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:4.94

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:1.24


title: 528 - mAdbID:73843

description: mAdb experiment ID: 73843

value: male

value: Submitting diagnosis:DLBCL

value: Follow up years:1.64

value: LDH ratio:0.85


title: 772 - mAdbID:70386

description: mAdb experiment ID: 70386

value: lymph node

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:2.48

value: LDH ratio:NA


title: 817 - mAdbID:70388

description: mAdb experiment ID: 70388

value: female

value: Lymphoma

value: Follow up status:DEAD

value: Follow up years:2.76

value: ECOG performance status:2

value: LDH ratio:0.78

value: Number of extranodal sites:0


title: 875 - mAdbID:70393

description: mAdb experiment ID: 70393

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:ALIVE

value: Follow up years:8.45

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:1.42


title: 717 - mAdbID:70380

description: mAdb experiment ID: 70380

value: male

value: lymph node

value: Submitting diagnosis:DLBCL

value: Follow up years:0.42

value: LDH ratio:4.15


title: 820 - mAdbID:70390

description: mAdb experiment ID: 70390

value: Lymphoma

value: Follow up years:1.59

value: ECOG performance status:0

value: LDH ratio:0.91


title: 710 - mAdbID:70378

description: mAdb experiment ID: 70378

value: female

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:DEAD

value: Follow up years:1.08

value: LDH ratio:2.78


title: 724 - mAdbID:70382

description: mAdb experiment ID: 70382

value: Follow up years:1.4

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:1.16

value: Number of extranodal sites:0


title: 449 - mAdbID:73840

description: mAdb experiment ID: 73840

value: male

value: lymph node

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up status:ALIVE

value: Follow up years:9.16

value: LDH ratio:0.72


title: 722 - mAdbID:70381

description: mAdb experiment ID: 70381

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up years:3.32

value: ECOG performance status:1

value: LDH ratio:1.78


title: 816 - mAdbID:70387

description: mAdb experiment ID: 70387

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:1.86

value: ECOG performance status:3

value: LDH ratio:10.2


title: 840 - mAdbID:70391

description: mAdb experiment ID: 70391

value: female

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:3.4

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:0

value: LDH ratio:0.6

value: Number of extranodal sites:0


title: 1009 - mAdbID:70396

description: mAdb experiment ID: 70396

value: lymph node

value: Lymphoma

value: Follow up status:ALIVE

value: Follow up years:9.68

value: LDH ratio:0.98

value: Number of extranodal sites:1


title: 460 - mAdbID:73841

description: mAdb experiment ID: 73841

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:9.02


title: 725 - mAdbID:70383

description: mAdb experiment ID: 70383

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:0.96

value: ECOG performance status:1

value: LDH ratio:0.74


title: 712 - mAdbID:70379

description: mAdb experiment ID: 70379

value: male

value: Follow up years:3.26

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:NA


title: 726 - mAdbID:70384

description: mAdb experiment ID: 70384

value: female

value: lymph node

value: Lymphoma

value: Follow up status:ALIVE

value: Follow up years:7.62

value: LDH ratio:0.82

value: Number of extranodal sites:0


title: 771 - mAdbID:70385

description: mAdb experiment ID: 70385

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:6.8


title: 709 - mAdbID:70377

description: mAdb experiment ID: 70377

value: Follow up status:DEAD

value: Follow up years:0.47

value: ECOG performance status:1

value: LDH ratio:1.44


title: 1061 - mAdbID:67514

description: mAdb experiment ID: 67514

value: male

value: Follow up years:1.04

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:1.04


title: 458 - mAdbID:73839

description: mAdb experiment ID: 73839

value: female

value: lymph node

value: Final microarray diagnosis:Unclassified DLBCL

value: Follow up years:1.18

value: Number of extranodal sites:1


title: 823 - mAdbID:70375

description: mAdb experiment ID: 70375

value: Lymphoma

value: Follow up years:0.16

value: ECOG performance status:3

value: LDH ratio:NA

value: Number of extranodal sites:0


title: 676 - mAdbID:70376

description: mAdb experiment ID: 70376

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:1

value: ECOG performance status:2

value: LDH ratio:1.47


title: 819 - mAdbID:70389

description: mAdb experiment ID: 70389

value: male

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:0.72

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:2.8


title: 421 - mAdbID:70374

description: mAdb experiment ID: 70374

value: female

value: lymph node

value: Follow up years:1.24

value: ECOG performance status:1

value: LDH ratio:0.72


title: 800 - mAdbID:67458

description: mAdb experiment ID: 67458

value: Lymphoma

value: Follow up years:0.33

value: Number of extranodal sites:0


title: 1000 - mAdbID:67466

description: mAdb experiment ID: 67466

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:0.69

value: ECOG performance status:3

value: LDH ratio:1.68


title: 681 - mAdbID:67463

description: mAdb experiment ID: 67463

value: male

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:9.7

value: LDH ratio:1.01


title: 533 - mAdbID:67451

description: mAdb experiment ID: 67451

value: lymph node

value: Follow up years:0.71

value: Chemotherapy:CHOP-Like Regimen

value: Number of extranodal sites:1


title: 912 - mAdbID:66603

description: mAdb experiment ID: 66603

value: female

value: Lymphoma

value: Follow up years:16.79

value: ECOG performance status:0


title: 544 - mAdbID:67503

description: mAdb experiment ID: 67503

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:1.31

value: ECOG performance status:2

value: LDH ratio:0.6


title: 646 - mAdbID:67506

description: mAdb experiment ID: 67506

value: male

value: Follow up years:2.59

value: LDH ratio:1.87

value: Number of extranodal sites:0


title: 1059 - mAdbID:67513

description: mAdb experiment ID: 67513

value: lymph node

value: Follow up years:2

value: LDH ratio:0.92


title: 1060 - mAdbID:67512

description: mAdb experiment ID: 67512

value: female

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:6.45

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:1.92

value: Number of extranodal sites:1


title: 803 - mAdbID:67464

description: mAdb experiment ID: 67464

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:1.45

value: ECOG performance status:2


title: 1057 - mAdbID:67510

description: mAdb experiment ID: 67510

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:2.13

value: LDH ratio:NA

value: Number of extranodal sites:0


title: 1051 - mAdbID:67508

description: mAdb experiment ID: 67508

value: female

value: lymph node

value: Follow up years:0.12

value: LDH ratio:10.34


title: 642 - mAdbID:67505

description: mAdb experiment ID: 67505

value: Follow up years:0.34

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:1.32


title: 714 - mAdbID:67507

description: mAdb experiment ID: 67507

value: Follow up years:2.45

value: ECOG performance status:1

value: LDH ratio:1


title: 858 - mAdbID:70392

description: mAdb experiment ID: 70392

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:3.58

value: LDH ratio:0.85


title: 821 - mAdbID:67460

description: mAdb experiment ID: 67460

value: male

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:9.47

value: LDH ratio:NA


title: 1055 - mAdbID:67509

description: mAdb experiment ID: 67509

value: female

value: lymph node

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:7.81

value: LDH ratio:0.66

value: Number of extranodal sites:0


title: 413 - mAdbID:70373

description: mAdb experiment ID: 70373

value: Follow up years:0.6

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:6.13

value: Number of extranodal sites:1


title: 645 - mAdbID:67438

description: mAdb experiment ID: 67438

value: Lymphoma

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:6.08

value: ECOG performance status:0

value: LDH ratio:1.96


title: 836 - mAdbID:66379

description: mAdb experiment ID: 66379

value: male

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:4.29

value: ECOG performance status:2

value: LDH ratio:0.62


title: 644 - mAdbID:67452

description: mAdb experiment ID: 67452

value: lymph node

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:0.31

value: LDH ratio:1.64

value: Number of extranodal sites:0


title: 847 - mAdbID:67461

description: mAdb experiment ID: 67461

value: female

value: Lymphoma

value: Follow up years:4.16

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:0.8


title: 541 - mAdbID:67436

description: mAdb experiment ID: 67436

value: Submitting diagnosis:DLBCL

value: Follow up years:4.11

value: LDH ratio:1.83


title: 779 - mAdbID:66384

description: mAdb experiment ID: 66384

value: male

value: Follow up status:DEAD

value: Follow up years:0.35


title: 652 - mAdbID:67454

description: mAdb experiment ID: 67454

value: lymph node

value: Follow up years:0.01

value: ECOG performance status:2

value: LDH ratio:NA


title: 995 - mAdbID:67465

description: mAdb experiment ID: 67465

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:6.65

value: LDH ratio:0.76

value: Number of extranodal sites:0


title: 996 - mAdbID:66380

description: mAdb experiment ID: 66380

value: Lymphoma

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:0.21

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:1

value: LDH ratio:6


title: 545 - mAdbID:67504

description: mAdb experiment ID: 67504

value: male

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:1.1

value: LDH ratio:0.68


title: 731 - mAdbID:66364

description: mAdb experiment ID: 66364

value: lymph node

value: Follow up years:10.18

value: ECOG performance status:0

value: LDH ratio:0.64


title: 832 - mAdbID:66375

description: mAdb experiment ID: 66375

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:4.01


title: 795 - mAdbID:66373

description: mAdb experiment ID: 66373

value: Lymphoma

value: Follow up years:3.43

value: Number of extranodal sites:0


title: 700 - mAdbID:66360

description: mAdb experiment ID: 66360

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:5.4

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:1.68


title: 839 - mAdbID:66236

description: mAdb experiment ID: 66236

value: male

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:0.29

value: LDH ratio:2

value: Number of extranodal sites:1


title: 678 - mAdbID:66348

description: mAdb experiment ID: 66348

value: female

value: lymph node

value: Follow up years:0.06

value: ECOG performance status:1

value: LDH ratio:NA


title: 753 - mAdbID:66367

description: mAdb experiment ID: 66367

value: Lymphoma

value: Follow up years:0.04

value: ECOG performance status:4

value: LDH ratio:1.56

value: Number of extranodal sites:0


title: 698 - mAdbID:66350

description: mAdb experiment ID: 66350

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:3.88

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:0.74


title: 627 - mAdbID:66232

description: mAdb experiment ID: 66232

value: male

value: Submitting diagnosis:DLBCL

value: Follow up status:DEAD

value: Follow up years:1.27

value: LDH ratio:0.49


title: 543 - mAdbID:66344

description: mAdb experiment ID: 66344

value: female

value: lymph node

value: Follow up years:3.47

value: ECOG performance status:1

value: LDH ratio:0.48


title: 550 - mAdbID:66345

description: mAdb experiment ID: 66345

value: Lymphoma

value: Follow up years:21.78

value: ECOG performance status:0

value: LDH ratio:NA


title: 577 - mAdbID:66346

description: mAdb experiment ID: 66346

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:ALIVE

value: Follow up years:1.65

value: LDH ratio:0.67

value: Number of extranodal sites:0


title: 661 - mAdbID:66235

description: mAdb experiment ID: 66235

value: male

value: Submitting diagnosis:DLBCL

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:0.56

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:0.66


title: 633 - mAdbID:66347

description: mAdb experiment ID: 66347

value: lymph node

value: Follow up years:2.02

value: ECOG performance status:1

value: LDH ratio:1.11

value: Number of extranodal sites:1


title: 702 - mAdbID:66362

description: mAdb experiment ID: 66362

value: female

value: Lymphoma

value: Follow up status:DEAD

value: Follow up years:4.13

value: LDH ratio:0.9


title: 462 - mAdbID:66343

description: mAdb experiment ID: 66343

value: Final microarray diagnosis:ABC DLBCL

value: Follow up years:7.49

value: Number of extranodal sites:0


title: 660 - mAdbID:66233

description: mAdb experiment ID: 66233

value: Submitting diagnosis:DLBCL

value: Follow up years:0.2

value: LDH ratio:1


title: 692 - mAdbID:66349

description: mAdb experiment ID: 66349

value: Follow up status:ALIVE

value: Follow up years:10.53

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:1.37


title: 626 - mAdbID:66231

description: mAdb experiment ID: 66231

value: male

value: lymph node

value: Follow up years:2.49

value: ECOG performance status:1

value: LDH ratio:0.74


title: 618 - mAdbID:66195

description: mAdb experiment ID: 66195

value: Lymphoma

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:5.65

value: LDH ratio:0.94


title: 619 - mAdbID:66230

description: mAdb experiment ID: 66230

value: female

value: Follow up years:8.76

value: LDH ratio:1.32

value: Number of extranodal sites:1


title: 523 - mAdbID:66190

description: mAdb experiment ID: 66190

value: Submitting diagnosis:DLBCL

value: Follow up status:ALIVE

value: Follow up years:8.36

value: ECOG performance status:0

value: Number of extranodal sites:0


title: 616 - mAdbID:66194

description: mAdb experiment ID: 66194

value: lymph node

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:0.99

value: Chemotherapy:CHOP-Like Regimen

value: LDH ratio:0.466


title: 517 - mAdbID:66191

description: mAdb experiment ID: 66191

value: male

value: Lymphoma

value: Final microarray diagnosis:GCB DLBCL

value: Follow up years:3.03

value: ECOG performance status:1

value: LDH ratio:NA


title: 524 - mAdbID:66192

description: mAdb experiment ID: 66192

value: female

value: Submitting diagnosis:DLBCL

value: Follow up years:5.88


title: 479 - mAdbID:66188

description: mAdb experiment ID: 66188

value: Follow up status:ALIVE

value: Follow up years:7.24

value: ECOG performance status:0

value: LDH ratio:0.76


title: 446 - mAdbID:66186

description: mAdb experiment ID: 66186

value: lymph node

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:2.82

value: LDH ratio:0.68

value: Number of extranodal sites:0


title: 835 - mAdbID:66198

description: mAdb experiment ID: 66198

value: Lymphoma

value: Follow up years:1.22

value: Chemotherapy:CHOP-Like Regimen

value: ECOG performance status:2

value: LDH ratio:1.9

value: Number of extranodal sites:1


title: 482 - mAdbID:66189

description: mAdb experiment ID: 66189

value: male

value: Submitting diagnosis:DLBCL

value: Follow up years:7.72

value: LDH ratio:NA


title: 477 - mAdbID:66187

description: mAdb experiment ID: 66187

value: Follow up years:1.7

value: ECOG performance status:0


title: 438 - mAdbID:66185

description: mAdb experiment ID: 66185

value: lymph node

value: Final microarray diagnosis:GCB DLBCL

value: Follow up status:ALIVE

value: Follow up years:8.15

value: LDH ratio:1.51


title: 730 - mAdbID:66351

description: mAdb experiment ID: 66351

value: Lymphoma

value: Final microarray diagnosis:ABC DLBCL

value: Follow up status:DEAD

value: Follow up years:1.03

value: ECOG performance status:1

value: LDH ratio:1.89

value: Number of extranodal sites:NA


title: 433 - mAdbID:66184

description: mAdb experiment ID: 66184

value: male

value: Submitting diagnosis:DLBCL

value: Follow up years:0.76

value: Chemotherapy:CHOP-Like Regimen

value: Number of extranodal sites:0


title: 428 - mAdbID:66182

description: mAdb experiment ID: 66182

value: lymph node

value: Follow up years:11.38

value: LDH ratio:5.8